197 related articles for article (PubMed ID: 27281113)
1. A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.
Bartholf DeWitt S; Eward WC; Eward CA; Lazarides AL; Whitley MJ; Ferrer JM; Brigman BE; Kirsch DG; Berg J
Vet Surg; 2016 Aug; 45(6):715-22. PubMed ID: 27281113
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.
Milovancev M; Townsend KL; Tuohy JL; Gorman E; Bracha S; Curran KM; Russell DS
Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443
[TBL] [Abstract][Full Text] [Related]
3. A novel imaging system permits real-time in vivo tumor bed assessment after resection of naturally occurring sarcomas in dogs.
Eward WC; Mito JK; Eward CA; Carter JE; Ferrer JM; Kirsch DG; Brigman BE
Clin Orthop Relat Res; 2013 Mar; 471(3):834-42. PubMed ID: 22972654
[TBL] [Abstract][Full Text] [Related]
4. Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs.
Milovancev M; Townsend KL; Bracha S; Gorman E; Curran K; Russell DS
Vet Surg; 2018 Jan; 47(1):36-43. PubMed ID: 29064583
[TBL] [Abstract][Full Text] [Related]
5. Shaved margin histopathology and imprint cytology for assessment of excision in canine mast cell tumors and soft tissue sarcomas.
Milovancev M; Townsend KL; Gorman E; Bracha S; Curran K; Russell DS
Vet Surg; 2017 Aug; 46(6):879-885. PubMed ID: 28460419
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
[TBL] [Abstract][Full Text] [Related]
7. Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery.
Baker-Gabb M; Hunt GB; France MP
Aust Vet J; 2003 Dec; 81(12):732-8. PubMed ID: 15080482
[TBL] [Abstract][Full Text] [Related]
8. Narrative operative reports inconsistently record surgical information relating to resection of soft tissue sarcomas and mast cell tumors in dogs.
O'Neill M; Wustefeld-Janssens BG; Tremolada G; Griffin M
J Am Vet Med Assoc; 2023 Oct; 261(10):1-5. PubMed ID: 37290758
[TBL] [Abstract][Full Text] [Related]
9. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.
Kry KL; Boston SE
Vet Surg; 2014 Feb; 43(2):182-9. PubMed ID: 24392683
[TBL] [Abstract][Full Text] [Related]
10. Incomplete histological margins following planned narrow excision of canine appendicular soft tissue sarcomas and mast cell tumors, using the residual tumor classification scheme.
Haine DL; Pittaway R; Berlato D; Demetriou J
Vet Surg; 2022 Oct; 51(7):1078-1086. PubMed ID: 35830150
[TBL] [Abstract][Full Text] [Related]
11. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.
Elmslie RE; Glawe P; Dow SW
J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288
[TBL] [Abstract][Full Text] [Related]
12. Soft-tissue sarcomas in dogs: a review.
Ehrhart N
J Am Anim Hosp Assoc; 2005; 41(4):241-6. PubMed ID: 15995161
[TBL] [Abstract][Full Text] [Related]
13. Marginal excision of cutaneous mast cell tumors in dogs was not associated with a higher rate of complications or prolonged wound healing than marginal excision of soft tissue sarcomas.
Cockburn E; Janovec J; Solano MA; L'Eplattenier H
J Am Vet Med Assoc; 2022 Jan; 260(7):741-746. PubMed ID: 35092664
[TBL] [Abstract][Full Text] [Related]
14. Radiation treatment for incompletely resected soft-tissue sarcomas in dogs.
McKnight JA; Mauldin GN; McEntee MC; Meleo KA; Patnaik AK
J Am Vet Med Assoc; 2000 Jul; 217(2):205-10. PubMed ID: 10909459
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of intraoperative fluorescence imaging-guided surgery in cancer-bearing dogs: a prospective proof-of-concept phase II study in 9 cases.
Cabon Q; Sayag D; Texier I; Navarro F; Boisgard R; Virieux-Watrelot D; Ponce F; Carozzo C
Transl Res; 2016 Apr; 170():73-88. PubMed ID: 26746803
[TBL] [Abstract][Full Text] [Related]
16. Grade shifts in recurrent canine soft tissue sarcomas and mast cell tumors.
Griffin MA; Hughes K; Altwal J; Seguin B; Wustefeld-Janssens B
J Am Vet Med Assoc; 2023 Sep; 261(9):1-8. PubMed ID: 37257826
[TBL] [Abstract][Full Text] [Related]
17. Canine soft tissue sarcoma managed in first opinion practice: outcome in 350 cases.
Bray JP; Polton GA; McSporran KD; Bridges J; Whitbread TM
Vet Surg; 2014 Oct; 43(7):774-82. PubMed ID: 24724565
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
19. The feasibility and utility of optical coherence tomography directed histopathology for surgical margin assessment of canine mast cell tumours.
Dornbusch JA; Cocca C; Jennings R; Samuelson J; Vieson M; Huang PC; Boppart SA; Wavreille VA; Selmic LE
Vet Comp Oncol; 2021 Dec; 19(4):616-623. PubMed ID: 32951309
[TBL] [Abstract][Full Text] [Related]
20. A quantitative microscopic approach to predict local recurrence based on in vivo intraoperative imaging of sarcoma tumor margins.
Mueller JL; Fu HL; Mito JK; Whitley MJ; Chitalia R; Erkanli A; Dodd L; Cardona DM; Geradts J; Willett RM; Kirsch DG; Ramanujam N
Int J Cancer; 2015 Nov; 137(10):2403-12. PubMed ID: 25994353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
